The Population Genetics of Pseudomonas aeruginosa Isolates from Different Patient Populations Exhibits High-Level Host Specificity by van Mansfeld, Rosa et al.
The Population Genetics of Pseudomonas aeruginosa
Isolates from Different Patient Populations Exhibits
High-Level Host Specificity
Rosa van Mansfeld
1*, Irene Jongerden
2, Martin Bootsma
3, Anton Buiting
4, Marc Bonten
1, Rob Willems
1
1Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands, 2Department of Intensive Care Medicine, University Medical Centre
Utrecht, Utrecht, The Netherlands, 3Julius Center for Health Research and Primary Care, University Medical Centre Utrecht, and Department of Mathematics, Faculty of
Science, Utrecht University, Utrecht, The Netherlands, 4Department of Medical Microbiology and Immunology, St Elisabeth Hospital, Tilburg, The Netherlands
Abstract
Objective: To determine whether highly prevalent P. aeruginosa sequence types (ST) in Dutch cystic fibrosis (CF) patients
are specifically linked to CF patients we investigated the population structure of P. aeruginosa from different clinical
backgrounds. We first selected the optimal genotyping method by comparing pulsed-field gel electrophoresis (PFGE),
multilocus sequence typing (MLST) and multilocus variable number tandem-repeat analysis (MLVA).
Methods: Selected P. aeruginosa isolates (n=60) were genotyped with PFGE, MLST and MLVA to determine the diversity
index (DI) and congruence (adjusted Rand and Wallace coefficients). Subsequently, isolates from patients admitted to two
different ICUs (n=205), from CF patients (n=100) and from non-ICU, non-CF patients (n=58, of which 19 were community
acquired) were genotyped with MLVA to determine distribution of genotypes and genetic diversity.
Results: Congruence between the typing methods was .79% and DIs were similar and all .0.963. Based on costs, ease,
speed and possibilities to compare results between labs an adapted MLVA scheme called MLVA9-Utrecht was selected as
the preferred typing method. In 363 clinical isolates 252 different MLVA types (MTs) were identified, indicating a highly
diverse population (DI =0.995; CI =0.993–0.997). DI levels were similarly high in the diverse clinical sources (all .0.981) and
only eight genotypes were shared. MTs were highly specific (.80%) for the different patient populations, even for similar
patient groups (ICU patients) in two distinct geographic regions, with only three of 142 ICU genotypes detected in both
ICUs. The two major CF clones were unique to CF patients.
Conclusion: The population structure of P. aeruginosa isolates is highly diverse and population specific without evidence for
a core lineage in which major CF, hospital or community clones co-cluster. The two genotypes highly prevalent among
Dutch CF patients appeared unique to CF patients, suggesting specific adaptation of these clones to the CF lung.
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Introduction
Pseudomonas aeruginosa can cause nosocomial infections in
immuno-compromised patients and patients in intensive care
units (ICUs), and is a major cause of morbidity and mortality in
patients with cystic fibrosis (CF) [1]. Molecular typing studies
revealed the presence of so-called epidemic strains, frequently
transmitted between CF patients and associated with higher
morbidity and mortality [2,3,4,5,6]. As a consequence, many
countries implemented segregation policies for CF patients [7].
In a previous cross-sectional study, investigating the population
structure of respiratory P. aeruginosa isolates among Dutch CF
patients by using multilocus sequence typing (MLST), we
described two sequence types (ST), ST406 and ST497 in 15%
and 5% of all patients infected with P. aeruginosa, respectively [8].
Both STs were not genetically linked to previously described
international epidemic clones, which were not detected in this CF
population.
In order to determine whether these prevalent STs are
specifically linked to patients with CF, or ubiquitously present in
other patient populations, we aimed to investigate the genetic
relatedness and population structure of P. aeruginosa isolates from
CF and non-CF patients. To do so, a highly discriminatory, cheap
and easy to perform typing scheme, which also allows results to be
easily compared with international databases, is required. Pulsed-
field gel electrophoresis (PFGE) has been the most widely used
typing method, but does not allow easy comparison of results of
different origin because of a relatively high degree of inter-
performer variation and lack of an international comparative
database. MLST provides sequence-based, and thus unambigu-
ous, results, but is rather expensive. We, therefore, first determined
whether multi-locus variable number tandem-repeat analysis
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comparing a new MLVA scheme, adjusted from the published
P. aeruginosa MLVA scheme [9], to PFGE and MLST. After
identifying the optimal typing scheme, based on discriminatory
power, typeability, time, ease of interpretation and of international
comparability and costs, we determined the population structure
of multiple P. aeruginosa isolates from different epidemiological
backgrounds.
Materials and Methods
Genotyping
To determine the optimal molecular typing method, 60 P.
aeruginosa isolates from sputum or throat swab cultures obtained
from 58 different CF patients visiting the University Medical
Centre Utrecht (UMCU) in 2007, were typed by PFGE, MLST
and MLVA9-Utrecht. This selection represented the genotypes
and genetic diversity found in the Dutch CF patients as shown in a
previous cross-sectional typing study. The Discriminatory Indices
(DI) and the 95% confidence intervals (CI) were calculated as
described before [10,11] using Bionumerics 5.1(Applied Maths, St-
Martens-Latem, Belgium). Criteria to assign isolates to clonal
clusters (CCs) were defined as follows: PFGE types (PT) .80%
similarity in band patters, MLVA types (MTs) with identical
numberofrepeats in8outof9loci(singlelocusvariants)and MLST
types (STs) with identical sequence in 6 out of 7 loci. CCs were
named after their presumed founder MT/ST, based on eBURST
criteria [12]. The quantitative level of congruence between typing
methods was calculated using the adjusted Rand and Wallace
coefficients, available at http://www.comparingpartitions.info/.
The adjusted Rand coefficient quantifies the global agreement
between two methods, whereas the Wallace coefficient indicates the
probability that two isolates classified as the same type by one
method are also classified as the same type by another method [13].
MLVA9-Utrecht profiles were clustered with Bionumerics software
(version 5.1) by using a categorical coefficient and a graphing
method called minimum spanning tree [14].
PFGE
For PFGE, 2% agarose plugs were made with equal volume
bacterial suspension of 3 McFarland. Plugs were incubated
overnight with 0.5 mg/ml lysozyme (Sigma-Aldrich, Zwijndrecht,
Netherlands) at 37uC. Next 1 mg/ml proteinase K (VWR,
International, Amsterdam, Netherlands) was added and plugs
were incubated overnight at 56uC.
Plugs were washed for 30 min at 37uC once with 10 mM tris/
1 mM EDTA (TE) buffer, then 0.75 mM phenyl-methyl-sulfonyl-
fluoride (PMSF) in TE buffer, and again with TE buffer. Plugs
were digested with SpeI5ml (50 U) in 25 ml NE buffer2 (Westburg,
Leusden, Netherlands) and 220 ml water overnight at 37uC.
Electrophoresis was performed with 1% agarosegel for 20 h at
6 V/cm with initial switch of 5.8 s and final switch of 38 s. P.
aeruginosa strain ATCC 27853 was used as reference at minimal 5
lanes in each gel. The gels were stained with ethidiumbromide and
bands were analysed with Bionumerics 5.1 (Applied Maths, St-
Martens-Latem, Belgium). The band patterns were compared
using the Dice-coefficient by using the unweighted pair group
method to determine band similarity. Band patterns that were
more than 80% identical were considered related conform the
Tenover criteria [15,16], which state that a 2–3 band difference
indicates related strains. On average we observed 16 bands in our
P. aeruginosa PFGE gels, resulting in the 80% cut-off. Typeability
was defined as all isolates that produced a band pattern divided by
all isolates tested.
MLST and MLVA
Isolates were taken from the freezer and cultured on Trypticase
Soy Agar II +5% sheep blood plates (Becton, The Netherlands)
overnight at 37uC. A loop (few colonies) of bacterial cells were
suspended in 20 ml lysis buffer (0.25% SDS, 0.05 M NaOH) and
incubated at 95uC for 20 min. The cell lysate was spun by short
centrifugation and diluted with 180 ml buffer (10 mM Tris-HCl,
pH 8.5). After thoroughly mixing, another centrifugation for
5 min at 16,0006g was performed to remove cell debris.
Supernatants were frozen at 220uC until further use. Two and
a half ml of the lysate was used in the PCR reactions for MLST and
MLVA.
For MLST a touchdown PCR was performed as described
before, adapted from the protocol by Curran et al [17] with
HotStarTaq Mastermix (Qiagen, Valencia, CA,USA). PCR
products were sequenced (BaseClear, Leiden, the Netherlands)
with the same primers as used for amplification. Sequences were
analyzed using Bionumerics 5.1 (Applied Maths, St-Martens-
Latem, Belgium).
Sequence types (STs) were compared to the P. aeruginosa
Multilocus Sequence Typing website (http://pubmlst.org/
paeruginosa/) developed by Keith Jolley [18] and new alleles
and profiles were sent to the curator A. Baldwin.
For MLVA typing a touchdown PCR was performed adapted
from the protocol by Vu-Thien et al adding Q-buffer (Qiagen
Benelux B.V., Venlo, the Netherlands) using the published
primers for the following variable-number-of-tandem-repeats
(VNTRs): ms77, ms127, ms142, ms211, ms213, ms215, ms216,
ms217 and ms223 (called MLVA9-Utrecht). The PCR was
conducted as follows: 10 min at 96uC, then 10 cycles of 30 s at
95uC, 30 s at 65uCw i t h1 uC less every cycle and 1 min at 72uC.
This was followed by 25 cycles of 30 s at 95uC, 30 s at 55uC and
1 min at 72uC, and a final incubation of 10 min at 72uC
followed. PCR products were separated on a 2% agarose gel by
electrophoresis next to 100 bp DNA ladder (Invitrogen, The
Netherlands). The size of each amplicon was measured using
Bionumerics 5.1 (Applied Maths, St-Martens-Latem, Belgium)
and the number of repeats was deduced by using the MLVA
alleles assignment table on the Pseudomonas aeruginosa genotyping
site (http://minisatellites.u-psud.fr/MLVAnet/). PA01 (ATCC
BAA47) was used as control for checking consistency of allele
assignments. Loci that repetitively did not yield a PCR product
were assigned allele ‘‘99’’ to be able to include these isolates in
subsequent cluster analysis. MLVA9-Utrecht types (MTs) were
compared with the international database ‘‘pseudomonas2007’’
created by Gilles (http://minisatellites.u-psud.fr/MLVAnet/).
Typeability was defined as the number of isolates for which
repeat numbers could be inferred for all 9 loci divided by all
isolates tested.
Patients and bacterial isolates
To determine the P. aeruginosa population structure, 363 isolates
were collected from four different patient populations: 100
respiratory isolates from 90 CF patients who either were cultured
because of an exacerbation or screened for their annual check-up
(group I) and 205 P. aeruginosa isolates from aspirate, sputum or
throat swab screening cultures from patients admitted to intensive
care units (ICU) (one isolate per type per patient) in two hospitals
in the Netherlands (126 isolates from 97 patients in hospital 1
(group IIa) and 79 isolates from 64 patients in hospital 2 (group
IIb). Screening cultures were executed on admission, twice weekly
thereafter and on discharge during a period of 14 months in both
hospitals. Hospital 1 is a tertiary referral (university) hospital and
patients were included in two ICUs (10 and 8 beds, of which 6 and
MLVA Typing of Pseudomonas
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population. Hospital 2 is non-university teaching hospital, located
80 kilometers from hospital 1, and here patients from two ICUs (8
and 8 beds, single rooms) also harboring a mixed adult patient
population were included. In both ICUs, CF patients were
excluded. In total, 1200 patients were admitted for more than
24 hours and screened (cultures were not available of 113
patients). Isolates of 161 of 194 colonized patients were typed
and included in this study. Group III consisted of 39 non-
respiratory clinical isolates from 38 non-CF patients and non-ICU
patients admitted to hospital 1. These 38 patients were mostly
long-stay patients (admitted . one month) in different wards,
including surgery, neurology, oncology and internal medicine.
Group IV consisted of 19 isolates from 19 non-CF and non-ICU
patients obtained within 48 hours after admission or during out-
patient clinic visits at hospital 1. These isolates are considered
‘‘community acquired’’. The community acquired isolates were
cultured mainly from eyes, ears, wounds and screening cultures of
patients admitted for stem cell transplantation. The ethical
committees (METC) of both the University Medical Center
Utrecht and the St Elisabeth Hospital Tilburg approved this study
and waived the requirement for informed consent (METC Utrecht
protocol number: 05/311, METC Tilburg protocol number:
0655), since cultures were obtained as part of the hospital
surveillance program or clinical practice.
Calculation of expected DI and MT distribution
The median value and the 95% confidence intervals for the DIs
and the overlap in types between different clinical sources was
calculated using Mathematica 7.0.1.0, (Wolfram Research,
Champaign, Ill), by distributing the isolates 100,000 times,
randomly, over the different clinical sources under the assumption
that genotypes do not cluster. The number of isolates per group
and the prevalence of the different MTs were considered fixed and
only the distribution over the different groups was randomized.
Results
Adjusted MLVA9-Utrecht scheme
We first adjusted the published P. aeruginosa MLVA scheme, as
originally described by Vu-Thien et al. The original scheme
contained 15 variable number tandem-repeat (VNTR) loci, of
which some, due to small repeat sizes, required analysis on a DNA
sequencer. To create a robust MLVA scheme that was easy to
perform without the need for a DNA sequencer, we tested
different combinations of the original 15 VNTR loci and
calculated the DIs for the different combinations in a set of 101
P. aeruginosa isolates (the 100 selected CF isolates plus PA01;
ATCC BAA47). VNTR loci that were not selected in the final
scheme were loci with too small repeat size (,15 nt) and loci that
could not be amplified in .10% of the isolates. Based on these
criteria we selected a subset of nine MLVA loci, ms77, ms127,
ms142, ms211, ms213, ms215, ms216, ms217, and ms223. This
scheme yielded a PCR product in 91-100% of the isolates and a
high discriminatory index of 0.984 (CI 0.972–0.996).
Comparison of typing methods
Subsequently we compared the adjusted MLVA9-Utrecht
scheme with PFGE and MLST by typing 60 P. aeruginosa isolates
from CF patients with the three methods. Typeability was 100%
for MLST and MLVA9-Utrecht, but only 91.7% for PFGE as 5
isolates yielded, repeatedly, no banding patterns with this
technique (Table 1). PFGE, MLVA9-Utrecht, and MLST
distinguished 52, 45, and 36 types, respectively, which could be
grouped in 33, 35, and 33 CCs. The DIs with 95% confidence
intervals (CI) were comparable, although PFGE was slightly more
discriminatory than MLST (Table 1). The three typing methods
were highly congruent at the CC level with an adjusted Rand
coefficient of 0.84 for PFGE vs. MLVA9-Utrecht, 0.91 for PFGE
vs. MLST and 0.90 for MLST vs. MLVA9-Utrecht. Moreover,
two strains that are of the same MT have a high probability of
belonging to the same ST on the level of clonal clusters, as
indicated by the Wallace coefficients (Table 2), which was highest
between MLVA9-Utrecht and MLST (0.969).
MLST-MLVA9-Utrecht comparison revealed that the previ-
ously identified high-prevalence STs among CF-patients, ST406
and ST497, were represented by MTs 27, 32, 52 and 238 and
MTs 11 and 38, respectively.
Based on the high DI of MLVA9-Utrecht, the high congruence
between this MLVA scheme and the other typing methods and the
fact that MLVA is considerably cheaper than MLST, rapid to
perform and allows data comparison with other datasets (Table 1),
we selected MLVA9-Utrecht as the preferred typing method to
determine the population structure of P. aeruginosa isolated from
different epidemiological backgrounds in the Netherlands.
Population biology of P. aeruginosa clinical isolates
All 363 isolates were typed with the adjusted 9 loci-MLVA
scheme and 252 different MLVA9-Utrecht types could be
discerned (typing data available in supplement Data S1). Type-
ability was 91% and ranged from 87% to 95% in the different
patient groups (Table 3). In 22 and 10 isolates one or two loci
Table 1. Typing characteristics of the genotyping methods for the 60 isolates typed with all 3 methods.
PFGE MLVA9-UTRECHT MLST
Typeability 91.7% 100% 100%
Costs
a J5.78 J7.21 J121.60
Time
b 5 days 2 days 7 days
Ease of interpretation - ++ +
International comparison
c - ++ +
Discriminatory Index 0.998 [0.995–1.0] 0.982 [0.968–0.998] 0.963 [0.936–0.991]
a:cost per isolate tested, including materials, excluding labor and equipment depreciation since that is similar in all methods. MLST costs can be lower when not using
outsourced sequencing.
b: Time can be shorter with MLST. In this study we outsourced sequencing that took extra time.
c: comparison with international data in database on http://pubmlst.org/paeruginosa/for MLST and http://minisatellites.u-psud.fr/MLVAnet/for MLVA.
doi:10.1371/journal.pone.0013482.t001
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‘‘99’’. Of the loci that could not be amplified in all isolates, ms217,
ms215 and ms77 could not be amplified in 12, 8 and 7 isolates,
respectively. Ms127 was the only locus that could be amplified in
all isolates. The genetic diversities in these four populations were
similarly high, with an overall DI of 0.995 (CI 0.993–0.997)
(Table 3).
The population structure of P. aeruginosa in this strain set based
on MLVA9-Utrecht is characterized by a high level of host-
specificity. Between 82% and 91% of MTs are unique for the
different patient populations. Only 11 (4%) of the 252 MTs were
detected in two different patient populations studied. These MTs
represented 11% of the CF related types (group I), 6% of the ICU
related types (group II), 9% of the non-ICU hospitalized patients
(group III) and 18% of the community acquired types (group IV),
respectively (table 4). The MTs found in groups III and IV
(hospitalized, non-ICU patients and patients with community
acquired isolates) were not found in groups I (CF patients) or II
(ICU patients). When comparing MTs from the ICU populations
in both hospitals, most MTs appeared to be ICU-specific (fig. 1/
table 4). Only three (2%) of 142 MTs were detected in samples
from patients in both ICUs indicating specific clustering in both
location and patient group. The DIs of CF group and ICU-1
group appeared significantly lower than what would have been
expected in case of random distribution of MTs (table 5).
Furthermore, calculation of expected unique and shared types
between the five groups in case of random distribution revealed
that the observed numbers of shared types between all the different
groups was significantly lower than what would have been
expected, except between group III and IV (table 4). This proves
non-random clustering of MTs and the presence of patient group-
specific types.
The 252 MTs could be grouped in 22 CCs, defined as clusters
of three or more types that share at least 8 out of 9 loci (fig. 1). The
minimum spanning tree revealed that specific clustering in both
location and patient group did not result in grouping of isolates
from a single patient population in one genetic lineage or genetic
subpopulation. In contrast, isolates belonging to a single patient
population are scattered over the minimum spanning tree. In
agreement with the observed host-specificity, only three CCs
contained isolates from four of the five populations studied. These
three CCs (CC44, CC255 and CC13) contain CF isolates that
were also typed by MLST allowing comparison with other isolates
in the MLST database [19]. These ‘‘mixed’’ CCs, detected in each
patient population, are closely related to P. aeruginosa clones that
had been detected up to 7 countries on 4 continents.
Three CCs contained isolates from CF patients only. Two of
these, CC27 and CC11, contained the two previously reported
high prevalent genotypes in CF-patients, ST406 and ST497,
represented in this study by MLVA9-Utrecht types MT 27, 32, 52
and 238 (CC27) and MT 11 and 38 (CC11), respectively. This
means that these two high prevalent CF clones are exclusively
found in CF patients (fig. 1).
Discussion
Using a simplified MLVA scheme for genotyping we have
demonstrated that the population structure of P. aeruginosa isolates
is highly diverse and population specific. This implies that most
clones specific for CF patients, including the highly prevalent
Dutch clones MT27, 32, 52, 238 (ST406) and MT 11, 38 (ST497),
are genetically distinct from clones from non-CF patients. The
high prevalence of these clones in CF patients, therefore, is
unlikely to result from transmission of particular dominant clones
from the non-CF reservoir. Moreover, ICU-wards from different
hospitals appeared to have location specific P. aeruginosa
populations.
MLVA9-Utrecht revealed that the P. aeruginosa population in the
different clinical settings is highly diverse with a DI of 0.995 with
no difference in diversity between hospital acquired and
community acquired strains. This corroborates with previous
findings in ICU patients [20,21].
Table 2. Wallace coefficients, indicating congruence between
the different typing methods.
MLVA9-UTRECHT MLST PFGE
MLVA9-UTRECHT NA 0.969 0.917
MLST 0.845 NA 0.918
PFGE 0.793 0.910 NA
doi:10.1371/journal.pone.0013482.t002
Table 3. P. aeruginosa MLVA9-UTRECHT typing results of four different patient populations.
group I group IIa group IIb group II group III group IV
CF ICU -I ICU-II ICU total
Hospital acquired
Non-CF/non-ICU
Community acquired
Non-CF/non-ICU Total
source respiratory respiratory respiratory respiratory non-respiratory non-respiratory diverse
# isolates
(from # pat)
100 (90) 126 (97) 79 (64) 205 (161) 39 (38) 19 (19) 363 (308)
typeability 88% 93% 100% 95% 87% 89% 91%
# types 72 82 63 142 33 17 252
Index of diversity 0.984 0.981 0.991 0.991 0.989 0.988 0.995
CI (0.971–0.996) (0.97–0.992) (0.983–0.999) (0.987–0.996) (0.977–1.0) (0.969–1.0) (0.993–0.997)
Prevalent
types ($5%)
MT27(11%)
MT11(5%)
MT44 (10%)
MT68 (6%)
MT161 (8%) NA MT255 (5%)
MT261 (5%)
MT276 (11%)
MT212 (11%)
NA
CF: cystic fibrosis patients, ICU: intensive care unit patients, MT: MLVA9-UTRECHT type,
#: number.
doi:10.1371/journal.pone.0013482.t003
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PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13482Figure 1. Minimum spanning tree of 363 P. aeruginosa isolates from different patient populations typed by MLVA9-UTRECHT. Circles
represent MTs, the size of the circle is related to the number of isolates with that specific MT in this collection. Fat lines between the circles represent
single locus variants (SLVs), differing only in one loci. Dotted lines represent double locus variants. Yellow color represents CF isolates, pink and
purple are ICU respiratory isolates from two different hospitals, blue are non-CF non-ICU isolates (dark blue are ‘‘community acquired’’ isolates and
light blue ‘‘hospital acquired’’). Grey shading indicates clonal complexes.
doi:10.1371/journal.pone.0013482.g001
Table 4. Numbers (%) of shared and unique MLVA9-UTRECHT types (MTs) in the four groups of clinical sources compared to the
numbers of expected values based on 100.000 permutations (median, range and 95% confidence interval (CI)) when assuming
random distribution of types.
MTs shared (percentage of total MTs) [95% CI]
Unique CF ICU-I ICU-2 HA CA
Source group I group IIa group IIb group III group IV
CF Observed 64 (89%) 6 (8%)
a 2 (3%)
a 0
a 0
a
Expected 58 [50–66] 18 [13–23] 13 [8–18] 8 [4–12] 4 [1–7]
ICU-1 Observed 72 (88%) 6 (7%)
a 3 (4%)
a 0
a 0
a
Expected 74 [66–82] 18 [12–23] 15 [10–20] 9 [5–13] 5 [2–8]
ICU-2 Observed 58 (92%)
b 2 (3%)
a 3 (5%)
a 0
a 0
a
Expected 46 [38–53] 13 [8–18] 15 [10–20] 7 [3–11] 3 [1–7]
HA Observed 30 (91%)
b 0
a 0
a 0
a 3 (9%)
Expected 23 [17–28] 8 [4–12] 9 [5–13] 7 [3–11] 2 [0–5]
CA Observed 14 (82%) 0
a 0
a 0
a 3 (18%)
Expected 10 [6–14] 4 [1–7] 5 [2–8] 3 [1–7] 2 [0–5]
CF: cystic fibrosis patients, ICU: intensive care unit patients, HA: non-CF, non-ICU patients with hospital acquired P. aeruginosa, CA: non-CF, non-ICU patients with
community acquired P. aeruginosa.
a: value lower than expected within 95% CI range, i.e. less overlap of types between sources than in the case of random distribution of types.
b: more unique genotypes per source than expected, i.e. high level of source-specificity rather than random distribution.
doi:10.1371/journal.pone.0013482.t004
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aeruginosa population structures, ranging from panmictic in the early
nineties [22,23] to more clonal in 2007 [24]. The latest reports
however, summarized by Pirnay in 2009, point towards a nonclonal
epidemic population structure, with no distinction between clinical
or environmental isolates [25]. In particular, the lack of distinction
in genotype, function and chemotaxonomy between clinical and
environmental P. aeruginosa isolates has been reported by different
research groups [26,27]. Based on FAFLP, gene sequencing and
virulence gene profiling Pirnay et al described that strains which
clustered in the same clonal complexes could have been isolated
from inanimate environments, animals and humans, sometimes
separated by thousands of miles. They concluded that there was no
correlation between the clonal complexes and geographical origin
or habitat. We also found that the three clonal complexes that were
present in the four epidemiological backgrounds had been detected
previously in up to seven other countries on four continents,
indicating their global presence [28].
However, in contrast to previous research that suggested no
correlation between P. aeruginosaclones and diseases or environmental
habitats [29], we found genotypes to be highly specific for the
different patient groups with only a relatively small number of clones
distributed across patient population boundaries. However, since the
MLVA database [28] does not provide data on the source of the
isolate we cannot elaborate on the association between these types
and epidemiological background. Our findings of high specificity of
different sets of genotypes, not only in the various patient groups but
also between ICUs in the different hospitals, are remarkable. Thus,
discordant to the proposed consensus of a non-clonal epidemic
population structure with some dominant clonal complexes, which
are justas versatile in their habitat and geographic origin as the whole
P. aeruginosa population, we found that both patient population and
geographical origin appeared to be correlated to the prevalence of
certaingenotypesandthattransmissionofP.aeruginosaclones between
ICUs, hospital wards and CF patients is rare.
The limited overlap between isolates from CF and non-CF
patients also fails to support findings reported by Lanotte et al, who
described, based on random amplification of polymorphic DNA
(RAPD), a non-random distribution of isolates but with a
subpopulation of isolates originating from patients with lung
disease, both CF and non-CF. This could result from low
discriminatory power of RAPD.
Pirnay et al also concluded that, based on typing of 328
unrelated isolates including 43 CF isolates, all CF isolates clustered
into a ‘‘core lineage’’ that is predominant in both disease and
environmental habitats across the world. Consequently, CF
isolates belonging to the so-called ‘‘successful core lineage’’ are
ubiquitous in the natural environment and are, therefore, more
likely to infect CF patients. We failed to confirm such a level of
‘‘relatedness’’ in our populations, as CF isolates, as well as the ICU
isolates and other clinical isolates were dispersed over the entire
minimum spanning tree. Moreover, the two most successful CF
clones in our country were not detected in other patient
populations and they are not genotypically closely related to
non-CF isolates. This suggests no common evolutionary back-
ground of P. aeruginosa isolates from CF patients nor of P. aeruginosa
isolates from the other analyzed patient groups. Our findings are
more in line with the observation that the Australian Epidemic
strains I and III (AESI and AESIII) could not be isolated from the
environment [30,31]. These findings suggest selection of multiple
specific clones with a distinct evolutionary background that are
better equipped to adapt to and survive in the specific conditions
in the CF lung. This also indicates that P. aeruginosa from many
different lineages can adapt to all kinds of niches. This concurs
with data from Pirnay et al, who found that a P. aeruginosa
community in a Belgian river contained members of nearly all
successful clonal complexes and was almost as diverse as the global
population, represented by 73 clinical and environmental isolates
from a previous study [32].
The strength of our study is the large and well-defined collection
of isolates and the ability of MLVA9-Utrecht to show, highly
reproducible, genotypic relatedness, with the possibility of
comparing the genotypes to results contained in international
databases via the internet, and that can be performed under point-
of-care conditions. One should be aware that the MTs assigned in
this study only refer to the MLVA9-Utrecht scheme. We did not
include isolates from the environment in our study, shown to
contain similar genotypes as clinical isolates in other studies, which
may change our findings of specificity.
We conclude that the population structure of P. aeruginosa from
different patient populations is highly diverse and characterized by
high-level host-specificity and by the presence of many unique and
only a limited number of more prevalent genotypes. The two
genotypes (MT27/ST406 and MT11/ST497), frequently found in
the Dutch CF patients, appear to be unique to CF patients and are
not found in other clinical patients. Further studies are needed to
elucidate the specific adaptations and survival strategies that these
strains have adopted to survive in this special niche.
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